Twelve months ago Ascent Industries was a company in two pieces: a money-losing metals-and-pipe business and a chemicals business that quietly underwrote it. A year of divestitures changed that. By the middle of 2025 the entire Tubular Products segment - BRISMET sold in April for roughly $45 million in cash, American Stainless Tubing in June for about $16 million - was gone, and Ascent became what it says it always meant to be: a single-segment specialty chemicals pure-play. The fiscal second quarter was the first full quarter of the new shape, and it was, in management's own words, "one of the strongest in our recent history." Net sales jumped 37.6% to $25.7 million, total gross profit rose 14% to $5.5 million, and adjusted EBITDA swung from a year-ago loss to $1.5 million. Sequentially the picture is even cleaner: legacy gross margin expanded roughly 710 basis points quarter over quarter, and adjusted EBITDA rose $1.8 million.
The quarter has two readings, and the difference matters. The read that looks like a triumph - record trailing-twelve-month volume, net sales, gross profit and adjusted EBITDA from continuing operations - is real but incomplete. The second look is the test Ascent still has to pass: gross margin of 21.6% remains well below the 26.1% of a year ago and below the company's own long-term target, and on a GAAP basis the segment-operated company is only barely past break-even, earning $0.07 a diluted share in the quarter and still posting a continuing-operations loss of $1.3 million for the first half. The stock trades at roughly $15.33 (market cap about $138 million) after a steady two-month climb from the mid-$13s - a price that has already begun to pay for the growth story. The question the next two quarters answer is whether a company that has proven it can grow can now prove it can convert that growth into margin and earnings at a multiple the market will respect.